Jamila Diabetes and Endocine Medical Center is categorized under Diabetes Doctors in , and active since 1994.
Jamila Diabetes and Endocine Medical Center was established in 1994, and today employs 1 to 4, earning Unknown per year. This is a Diabetes Doctors business, which does work in the B2C market, and is classified as a Diabetes Doctors, under code number by the NAICS.
If you are seeking more information, feel free to contact sarfraz zaidi at the company’s single location by writing to 1429 E. Thousand Oaks Blvd. Suite 105, Thousand Oaks, CA 91362, , 93162 or by phoning (805) 495-7143. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Jamila Diabetes and Endocine Medical Center |
Contact Person: | sarfraz zaidi |
Address: | 1429 E. Thousand Oaks Blvd. Suite 105, Thousand Oaks, CA 91362, , 93162 |
Phone Number: | (805) 495-7143 |
Website Address: | onlinemedinfo.com |
Annual Revenue (USD): | Unknown |
Founded: | 1994 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Diabetes Doctors |
Share This Business: |
Jamila Diabetes and Endocine Medical Center was started in 1994 to provide professional Diabetes Doctors under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact sarfraz zaidi for inquiries that concern Jamila Diabetes and Endocine Medical Center by calling the company number (805) 495-7143, as your correspondence is most welcome. Additionally, the physical location of the single location of Jamila Diabetes and Endocine Medical Center can be found at the coordinates 34.178654,-118.854645 as well as the street address 1429 E. Thousand Oaks Blvd. Suite 105, Thousand Oaks, CA 91362 in , 93162.
For its online presence, you may visit Jamila Diabetes and Endocine Medical Center’s website at onlinemedinfo.com and engage with its social media outlets through on Twitter and on Facebook.